- Home
- SNGX vs WORX Comparison
SNGX vs WORX Comparison
Compare SNGX & WORX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- WORX
- Stock Information
- Founded
- SNGX 1987
- WORX N/A
- Country
- SNGX United States
- WORX United States
- Employees
- SNGX N/A
- WORX N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- WORX Services-Misc. Amusement & Recreation
- Sector
- SNGX Health Care
- WORX Consumer Discretionary
- Exchange
- SNGX Nasdaq
- WORX Nasdaq
- Market Cap
- SNGX 7.5M
- WORX 1.9M
- IPO Year
- SNGX 1987
- WORX N/A
- Fundamental
- Price
- SNGX $3.74
- WORX $1.08
- Analyst Decision
- SNGX
- WORX
- Analyst Count
- SNGX 0
- WORX 0
- Target Price
- SNGX N/A
- WORX N/A
- AVG Volume (30 Days)
- SNGX 116.0K
- WORX 82.3K
- Earning Date
- SNGX 08-09-2024
- WORX 09-17-2024
- Dividend Yield
- SNGX N/A
- WORX N/A
- EPS Growth
- SNGX N/A
- WORX N/A
- EPS
- SNGX N/A
- WORX N/A
- Revenue
- SNGX $494,623.00
- WORX $3,922,513.00
- Revenue This Year
- SNGX N/A
- WORX N/A
- Revenue Next Year
- SNGX $76.64
- WORX N/A
- P/E Ratio
- SNGX N/A
- WORX N/A
- Revenue Growth
- SNGX N/A
- WORX N/A
- 52 Week Low
- SNGX $1.83
- WORX $0.97
- 52 Week High
- SNGX $32.00
- WORX $6.30
- Technical
- Relative Strength Index (RSI)
- SNGX 46.76
- WORX 45.99
- Support Level
- SNGX $3.27
- WORX $0.98
- Resistance Level
- SNGX $4.67
- WORX $1.38
- Average True Range (ATR)
- SNGX 0.56
- WORX 0.18
- MACD
- SNGX 0.04
- WORX 0.02
- Stochastic Oscillator
- SNGX 22.07
- WORX 20.43
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About WORX SCWorx Corp.
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics.